CMS plan to slash $1.6 billion from 340B program will reduce discounts on cancer drugs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Hospitals enrolled in the 340B program stand to lose up to $1.6 billion in Medicare Part B reimbursements through upcoming cuts to the drug pricing program, according to a final rule by the Centers for Medicare and Medicaid Services.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Matthew Bin Han Ong
Matthew Bin Han Ong

Login